Conagra Brands, Inc.
CAG
$13.43
+4.51%
Conagra Brands, Inc. is a major packaged food company operating predominantly in the United States, with a portfolio spanning frozen foods, snacks, shelf-stable staples, and refrigerated products under well-known brands like Marie Callender's, Healthy Choice, Duncan Hines, and Slim Jim. The company is a significant, established player in the consumer defensive sector, competing as a volume-driven operator in mature, slow-growth categories. The current investor narrative is dominated by significant financial distress and a crisis of confidence, as evidenced by a plunging stock price, a CEO transition, and intense debate over the sustainability of its high dividend yield amid weak sales, margin pressures, and a challenging inflationary environment for input costs.…
CAG
Conagra Brands, Inc.
$13.43
Related headlines
Investment Opinion: Should I buy CAG Today?
Rating: Hold. The core thesis is that while the stock is cheap on a sales basis, the severe and accelerating deterioration in fundamentals justifies the discount and creates an unattractive risk/reward profile for new capital.
The supporting evidence for a Hold is multifaceted. Valuation is distressed at a PS of 0.92x, but this is countered by negative revenue growth of -6.8% YoY and a catastrophic swing to a -22.28% net margin. The forward P/E of 8.23x is low but meaningless if forward EPS estimates of $1.95 prove unattainable. The high 6.25% dividend yield is a lure, but its sustainability is the central question. Analyst sentiment provides no catalyst, with consensus ratings clustered around Neutral/Hold/Underweight.
The thesis would upgrade to a Buy only if the company demonstrates a clear reversal in the next quarterly report: specifically, a return to positive net income and a stabilization of gross margins above 24%. It would downgrade to a Sell on a confirmed dividend cut or a break below the $12.53 support level on high volume. Relative to its history and troubled peers, the stock is fairly valued for the high level of risk it presents, not undervalued.
Sign up to view all
CAG 12-Month Price Forecast
The outlook for CAG is overwhelmingly challenged. The probability-weighted expected return is negative, with the high-probability base case offering minimal upside from current levels. The bear case, involving a dividend cut, carries a meaningful 30% probability and significant downside. The AI stance is bearish due to the severity of the recent fundamental breakdown, which overshadows the cheap valuation. Confidence is medium (not high) because the stock is already near its lows, and any positive surprise on margins could trigger a sharp but likely temporary rally. The stance would upgrade to neutral only upon clear evidence of quarterly profitability restoration and would not turn bullish without several consecutive quarters of demonstrated execution.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Conagra Brands, Inc.'s 12-month outlook, with a consensus price target around $17.46 and implied upside of +30.0% versus the current price.
Average Target
$17.46
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$11 - $17
Analyst target range
Analyst coverage for Conagra appears limited, with only two analysts providing estimates for future revenue and EPS, suggesting waning institutional interest. The available institutional ratings data shows a consensus that leans bearish to neutral, with recent actions including a downgrade to 'Underweight' by Wells Fargo and a series of 'Hold', 'Neutral', 'Equal Weight', and 'Sector Perform' ratings from firms like Deutsche Bank, JP Morgan, Morgan Stanley, UBS, and RBC Capital. The lack of a published average target price in the data, coupled with the minimal analyst count, implies insufficient consensus data to calculate a reliable upside or downside. The wide dispersion in recent rating actions and the absence of bullish calls signal high uncertainty and a lack of conviction. This limited coverage is typical for a company facing severe headwinds, and it can lead to higher volatility and less efficient price discovery as the stock is driven more by fundamental news flow and macro sentiment than by analyst revisions.
Bulls vs Bears: CAG Investment Factors
The bear case currently holds significantly stronger evidence, anchored by a catastrophic collapse in profitability, accelerating revenue declines, and severe liquidity concerns. The bull case rests almost entirely on a deeply distressed valuation that may already price in a worst-case scenario. The single most important tension in the investment debate is the sustainability of the dividend. If management can stabilize operations and protect the payout using strong TTM free cash flow, the high yield could attract buyers and form a valuation floor. However, if the recent quarterly losses persist and force a dividend cut—a high-probability event given the -22.28% net margin—the last remaining pillar of investor support would crumble, likely triggering another leg down in the stock price.
Bullish
- Deeply distressed valuation: The stock trades at a trailing PS ratio of 0.92x, a substantial discount to the packaged food industry average of 1.5x-2.5x and at the absolute bottom of its own historical PS range. This embeds a worst-case scenario, leaving room for significant multiple expansion if the company stabilizes.
- Strong free cash flow generation: Despite quarterly losses, the company generated $876.4 million in TTM free cash flow, providing a crucial lifeline to fund operations and the dividend. This cash generation is a key pillar of financial resilience.
- High dividend yield signals potential value: The current dividend yield of 6.25% is exceptionally high for a consumer defensive stock, attracting income-focused investors. While the sustainability is in question, the yield provides a tangible return while waiting for a potential turnaround.
- Price near 52-week low limits downside: At $13.20, the stock is trading just 5.3% above its 52-week low of $12.53. This proximity to a technical floor suggests the majority of negative sentiment is priced in, reducing near-term downside risk from current levels.
Bearish
- Severe profitability collapse: The latest quarter reported a catastrophic net loss of -$663.6 million and a net margin of -22.28%, a stark reversal from a $164.5 million profit the prior quarter. This indicates fundamental operational breakdown, not just cyclical pressure.
- Accelerating revenue decline: Revenue contracted 6.8% YoY in the latest quarter, deteriorating from prior periods of growth. This negative trajectory in mature categories suggests eroding market share and pricing power.
- Dividend sustainability at severe risk: The high 6.25% yield is a symptom of distress, not strength, as highlighted by recent news questioning its viability. Funding a dividend from cash flow becomes untenable if quarterly losses of this magnitude persist.
- Weak liquidity and analyst abandonment: A current ratio of 0.71 signals potential difficulty meeting short-term obligations. Furthermore, coverage is limited to just 2 analysts with a consensus of neutral/hold ratings, indicating waning institutional confidence and support.
CAG Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 38.60% over the past year. As of the latest close of $13.20, the price is trading near the bottom of its 52-week range, just 5.3% above the 52-week low of $12.53 and 39.4% below the 52-week high of $21.78. This positioning deep in the lower quartile of its range signals severe bearish momentum and investor capitulation, presenting a potential value trap rather than a clear opportunity. Recent momentum remains decisively negative, with the stock down 12.93% over the past three months and 5.24% over the past month, indicating the downtrend is accelerating. This short-term weakness starkly contrasts with the broader market's strength, as evidenced by a relative strength of -28.07% over three months and -5.98% over one month versus the SPY. The stock's beta of -0.042 suggests it has been moving inversely to the market, exhibiting defensive characteristics that have failed to materialize as a safe haven during this sell-off. Key technical support is firmly established at the 52-week low of $12.53, while resistance lies at the recent breakdown level near the 52-week high of $21.78. A decisive break below $12.53 could trigger another leg down, while any recovery would need to reclaim the $15-$16 zone to suggest a meaningful reversal is underway.
Beta
-0.04
-0.04x market volatility
Max Drawdown
-45.5%
Largest decline past year
52-Week Range
$13-$22
Price range past year
Annual Return
-37.9%
Cumulative gain past year
| Period | CAG Return | S&P 500 |
|---|---|---|
| 1m | -1.0% | -1.6% |
| 3m | -12.3% | +11.7% |
| 6m | -21.4% | +6.3% |
| 1y | -37.9% | +22.2% |
| ytd | -22.4% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CAG Fundamental Analysis
Revenue growth is negative and deteriorating, with the most recent quarterly revenue of $2.98 billion representing a 6.8% year-over-year decline. This follows a multi-quarter trend of deceleration, moving from positive growth in prior periods to a significant contraction, indicating deep-seated challenges with volume and pricing power in its core categories. The Refrigerated & Frozen segment, contributing $1.25 billion, and Grocery & Snacks, at $1.21 billion, are the largest revenue drivers but are clearly under pressure. Profitability has collapsed into significant losses, with the latest quarter reporting a net income of -$663.6 million and a gross margin of 23.44%. This compares starkly to a net income of $164.5 million and a gross margin of 24.33% in the prior quarter, showing severe margin compression and a swing to deep unprofitability driven by substantial other expenses. The trailing twelve-month free cash flow of $876.4 million provides a crucial lifeline, but the quarterly net margin of -22.28% raises serious sustainability concerns. The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.90, but financial health is strained by a weak current ratio of 0.71, indicating potential liquidity challenges in covering short-term obligations. The company's return on equity of 12.90% appears respectable on a TTM basis but is likely inflated by the equity base being reduced by recent losses.
Quarterly Revenue
$3.0B
2025-11
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$876400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CAG Overvalued?
Given the company reported a significant net loss of -$663.6 million in its latest quarter, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Conagra trades at a trailing PS ratio of 0.92 and a forward PS implied by estimates of approximately 0.93, indicating the market assigns a sales multiple below 1x. This suggests the market is pricing the company at a discount to its annual revenue, often a sign of deeply distressed fundamentals or expectations of continued erosion. Compared to industry averages for packaged foods, a PS ratio below 1x represents a substantial discount, as many peers trade between 1.5x and 2.5x sales. This deep discount is justified by Conagra's negative growth profile, collapsing profitability, and high financial risk relative to more stable competitors. Historically, the stock's own PS ratio has fluctuated significantly, from a low near 0.92 currently to highs above 6.7x in recent years. Trading at the absolute bottom of its multi-year historical PS range signals the market is pricing in a worst-case scenario, embedding expectations of permanent impairment to its sales base, margin structure, or dividend sustainability.
PE
9.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -54x~111x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company's profitability has imploded, with the latest quarter showing a net loss of -$663.6 million and a gross margin compressing to 23.44% from 24.33% the prior quarter. This margin pressure, combined with a 6.8% YoY revenue decline, creates a vicious cycle that threatens the dividend, which consumes cash flow. Liquidity is a concern with a weak current ratio of 0.71, and the debt-to-equity of 0.90, while moderate, becomes more burdensome as earnings vanish.
Market & Competitive Risks are elevated due to Conagra's discounted but precarious position. Trading at a PS ratio of 0.92x represents a deep discount to peers, but this discount is justified and could compress further if fundamentals worsen. The stock's beta of -0.042 indicates it has moved inversely to the strong market, failing as a defensive safe haven and instead acting as a company-specific value trap. Competitive and inflationary pressures, as noted in recent news regarding rising fertilizer and input costs, threaten to further squeeze margins in its low-growth, price-sensitive categories.
Worst-Case Scenario involves a continuation of the current operational breakdown leading to a dividend suspension. A chain of weak next-quarter earnings, a guidance cut by the new CEO, and a subsequent dividend reduction would validate the deepest fears. This could trigger a final wave of capitulation from income-focused shareholders. The realistic downside would be a re-test and break below the 52-week low of $12.53, potentially falling to the $10-$11 range where the stock would trade purely on breakup value, implying a further 15-25% loss from the current $13.20 price.
FAQ
The key risks, in order of severity, are: 1) Dividend Suspension Risk: The high yield is unsustainable if recent quarterly losses of -$663.6 million persist, threatening a cut that would crash the stock. 2) Operational Collapse: Accelerating revenue decline (-6.8% YoY) and margin compression indicate a breakdown in its core business model. 3) Liquidity Strain: A weak current ratio of 0.71 could force unfavorable financing or asset sales. 4) Leadership Uncertainty: The recent CEO transition adds execution risk during a crisis. 5) Analyst Abandonment: Limited coverage with neutral/hold ratings suggests a lack of institutional catalyst.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock range-bound between $13 and $14.50 as the company struggles without improving. The Bear Case (30% probability) forecasts a drop to $10.50-$12.50 following a dividend cut. The Bull Case (20% probability) envisions a rally to $16.50-$18.00 on a successful turnaround. The Base Case is most likely, implying minimal expected return from the current $13.20 price. The key assumption behind this muted outlook is that the severe profitability issues witnessed in the last quarter will not be quickly resolved.
CAG is fairly valued relative to its current risk profile, not undervalued. It trades at a deep discount to its industry (PS of 0.92x vs. peer range of 1.5x-2.5x) and at the bottom of its own historical PS range. However, this discount is fully justified by its negative growth, collapsing profitability (-22.28% net margin), and high financial risk. The market is pricing in expectations of continued fundamental erosion and a high probability of a dividend cut. Therefore, the stock is not cheap enough to compensate for the substantial operational risks it faces.
CAG is not a good stock to buy for most investors at this time. While the 6.25% dividend yield and PS ratio of 0.92x appear attractive, they are symptoms of severe financial distress, not value. The company reported a catastrophic quarterly net loss of -$663.6 million, and revenue is declining at -6.8% YoY. The high probability of continued operational challenges and a potential dividend cut creates an unfavorable risk/reward profile. It could only be considered a speculative buy by deep-value investors with a very high risk tolerance and a multi-year horizon, betting on an unlikely successful turnaround.
CAG is unsuitable for short-term trading due to its negative momentum, lack of catalysts, and high volatility risk around earnings. It is also a poor fit for traditional long-term income investing because the core dividend is at severe risk. If an investor chooses to hold, it must be with a speculative, long-term (3-5 year) turnaround horizon, accepting the high likelihood of further downside before any potential recovery. The stock's negative beta of -0.042 shows it hasn't acted as a defensive holding, negating that typical long-term rationale. A minimum holding period cannot be responsibly recommended given the fundamental crisis.